The 1st issue of 2021 is online!
This week, we'll share some highlights.
For content alerts https://t.co/PgQbd2OXjq

Letters, conf reports, articles, reviews & commentaries about
https://t.co/SeEu2hfwdT

7 6

Happy to report our study on mutations/amplification in metastatic KRAS amplification likely confers resistance to anti-EGFR therapy. An excellent collaboration between https://t.co/5UztaMBBOT

27 60

Our first issue is live! Including an introduction to the journal by the Editors, in-depth reviews on the management of and in plus much more! All free to read with registration! Follow https://t.co/P6ctBsjcX5

52 92